Fred C - Search Results

1

Characteristics of women at risk for psychosocial distress in the year after breast cancer.

Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L. Schag CA, et al. Among authors: fred c. J Clin Oncol. 1993 Apr;11(4):783-93. doi: 10.1200/JCO.1993.11.4.783. J Clin Oncol. 1993. PMID: 8478672 Clinical Trial.

2

Predicting psychosocial risk in patients with breast cancer.

Ganz PA, Hirji K, Sim MS, Schag CA, Fred C, Polinsky ML. Ganz PA, et al. Among authors: fred c. Med Care. 1993 May;31(5):419-31. doi: 10.1097/00005650-199305000-00004. Med Care. 1993. PMID: 8501990 Clinical Trial.

3

Breast cancer survivors: psychosocial concerns and quality of life.

Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L. Ganz PA, et al. Among authors: fred c. Breast Cancer Res Treat. 1996;38(2):183-99. doi: 10.1007/BF01806673. Breast Cancer Res Treat. 1996. PMID: 8861837

4

Quantitative and qualitative assessment of a case management program for cancer patients.

Polinsky ML, Fred C, Ganz PA. Polinsky ML, et al. Among authors: fred c. Health Soc Work. 1991 Aug;16(3):176-83. doi: 10.1093/hsw/16.3.176. Health Soc Work. 1991. PMID: 1654296

5

Risk environments facing potential users of a supervised injection site in Ottawa, Canada.

Shaw A, Lazarus L, Pantalone T, LeBlanc S, Lin D, Stanley D, Chepesiuk C, Patel S, Tyndall M; PROUD Community Advisory Committee. Shaw A, et al. Harm Reduct J. 2015 Oct 22;12:49. doi: 10.1186/s12954-015-0083-9. Harm Reduct J. 2015. PMID: 26493319 Free PMC article.

6

Micronucleus induction in the bone marrow of rats by pharmacological mechanisms. II: long-acting beta-2 agonism.

Pontén I, Mutch P, Nicholls DJ, Saad A, Pohl CD, Young A, Fred C, O'Donovan MR, Åberg P. Pontén I, et al. Among authors: fred c. Mutagenesis. 2013 Mar;28(2):233-9. doi: 10.1093/mutage/ges078. Mutagenesis. 2013. PMID: 23408845

7

Intraoperatively acquired pressure ulcers and perioperative normothermia: a look at relationships.

Fred C, Ford S, Wagner D, Vanbrackle L. Fred C, et al. AORN J. 2012 Sep;96(3):251-60. doi: 10.1016/j.aorn.2012.06.014. AORN J. 2012. PMID: 22935254

8

In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.

Dobo KL, Greene N, Fred C, Glowienke S, Harvey JS, Hasselgren C, Jolly R, Kenyon MO, Munzner JB, Muster W, Neft R, Reddy MV, White AT, Weiner S. Dobo KL, et al. Among authors: fred c. Regul Toxicol Pharmacol. 2012 Apr;62(3):449-55. doi: 10.1016/j.yrtph.2012.01.007. Epub 2012 Jan 31. Regul Toxicol Pharmacol. 2012. PMID: 22321701

9

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators. Leiter LA, et al. Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x. Diabet Med. 2011. PMID: 21679231

10

Optimization of a radiolabel DNA-binding assay in cultured mammalian cells.

Pohl CD, Priestley CC, O'Donovan M, Bolcsfoldi G, Fred C. Pohl CD, et al. Among authors: fred c. Mutat Res. 2011 Aug 16;723(2):134-41. doi: 10.1016/j.mrgentox.2011.04.014. Epub 2011 May 27. Mutat Res. 2011. PMID: 21640194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page